Top Drug Makers Keep Price Hikes Shy Of 10 Percent

New analysis from a top investment firm reveals that a number of the world's top drug companies increased drug prices by just below 10 percent in late December and early January. While keeping hikes below 10 percent allows the companies to follow along with the so-called social contract with consumers first started by Allergan, two consumer groups are still calling foul. Despite some murmuring by consumer advocates about these price increases, industry leaders appear calm over the threat of top-down...